Out-of-pocket costs for families and people living with cerebral palsy in Australia

被引:9
|
作者
Henry, Georgina [1 ]
Webb, Annabel [1 ]
Galea, Claire [1 ]
Pearce, Alison [2 ,3 ]
Balde, Isabelle [1 ]
Garrity, Fiona [4 ]
Marmont, Sophie [4 ]
Espie, James [4 ]
Badawi, Nadia [1 ,5 ]
McIntyre, Sarah [1 ]
机构
[1] Univ Sydney, Cerebral Palsy Alliance Res Inst, Specialty Child & Adolescent Hlth, Sydney, NSW, Australia
[2] Univ Sydney, Daffodil Ctr, Joint Venture Canc Council NSW, Sydney, NSW, Australia
[3] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia
[4] Cerebral Palsy Alliance, CP Quest, Sydney, NSW, Australia
[5] Childrens Hosp Westmead, Grace Ctr Newborn Care, Sydney, NSW, Australia
来源
PLOS ONE | 2023年 / 18卷 / 07期
关键词
YOUNG-CHILDREN; IMPACT; DISABILITY;
D O I
10.1371/journal.pone.0288865
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The most recent cost estimates of cerebral palsy (CP) in Australia did not include out-of-pocket costs for families. This study aimed to: 1) describe and estimate out-of-pocket costs for people with CP and their families by age and gross motor function classification system (GMFCS) level; 2) measure financial distress. A cross-sectional quantitative survey design was used with qualitative approaches to analyse open-ended questions. A CP-specific out-of-pocket costs survey was co-designed with people with lived experience. Adults with CP and carers were recruited from Australian population-based CP Registers and via social media. Sociodemographic variables were analysed descriptively and median (IQR) expenses for health, assistive technology, personal care, housing, occupation, transport, leisure, respite and holidays, by age (0-6; 7-17; 18 years +) and gross motor function [GMFCS level I-II vs III-V] were calculated. The In Charge Financial Distress/Financial Wellbeing Scale measured financial distress. Regression analyses were conducted to investigate costs and financial distress. Additional out-of-pocket costs itemised in open-ended questions were charted. Comments were thematically analysed using the framework approach. 271 surveys were completed for children 0-6 years (n = 47), children/adolescents 7-17 years (n = 124) and adults (n = 100). 94% of participants had out-of-pocket costs associated with CP, with an overall annual median of $4,460 Australian dollars (IQR $11,955). After controlling for income, private insurance and disability funding, the GMFCS III-V group had costs two times higher than the GMFCS I-II group (2.01; 95% CI 1.15-3.51). Age was not significantly associated with costs. 36% of participants had high to overwhelming financial distress; this was not associated with age or GMFCS level after controlling for financial factors. Families had several additional disability costs. Open-ended responses revealed experiences of financial concern were influenced by funding scheme experiences, reduced income, uncertainty, access to support networks and an inability to afford CP-related costs. Cost estimates and financial distress indicators should inform policy, funding and clinical decisions when planning interventions to support people with CP and their families.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Out-of-Pocket Costs for Hepatitis C Virus Treatments
    Teply, Robyn
    Goodman, Mark
    Mukherjee, Sandeep
    Guck, Thomas
    Simari, Caroline
    HEPATOLOGY, 2017, 66 : 330A - 331A
  • [32] Out-of-Pocket Costs and Prescription Reversals With Oral Linezolid
    Pasquale, Margaret K.
    Louder, Anthony M.
    Deminski, Michael C.
    Chambers, Richard B.
    Haider, Seema
    AMERICAN JOURNAL OF MANAGED CARE, 2013, 19 (09): : 734 - 740
  • [33] LOWER OUT-OF-POCKET COSTS ASSOCIATED WITH PEGFILGRASTIM BIOSIMILARS
    Wang, C. Y.
    Vouri, S. M.
    Park, H.
    Heldermon, C. D.
    Brown, J. D.
    VALUE IN HEALTH, 2022, 25 (07) : S418 - S418
  • [34] Effect of Out-of-Pocket Costs on Subsequent Mammography Screening
    Tran, Linh
    Chetlen, Alison L.
    Leslie, Douglas L.
    Segel, Boel E.
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2022, 19 (01) : 24 - 34
  • [35] Rising out-of-pocket costs in disease management programs
    Chernew, ME
    Rosen, AB
    Fendrick, AM
    AMERICAN JOURNAL OF MANAGED CARE, 2006, 12 (03): : 150 - 154
  • [36] Full Disclosure - Out-of-Pocket Costs as Side Effects
    Ubel, Peter A.
    Abernethy, Amy P.
    Zafar, S. Yousuf
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (16): : 1484 - 1486
  • [37] The Burden of Out-of-Pocket and Indirect Costs of Prostate Cancer
    Jayadevappa, Ravishankar
    Schwartz, J. Sanford
    Chhatre, Sumedha
    Gallo, Joseph J.
    Wein, Alan J.
    Malkowicz, S. Bruce
    PROSTATE, 2010, 70 (11): : 1255 - 1264
  • [38] Out-of-pocket costs to users: Medicine options for hypertension
    Arredondo, Armando
    AMERICAN JOURNAL OF HYPERTENSION, 2008, 21 (05) : 492 - 492
  • [39] Out-of-pocket costs for oral anticancer drugs.
    Arora, Nivedita
    Hussaini, S. M. Qasim
    Sedhom, Ramy
    Blaes, Anne Hudson
    Dusetzina, Stacie B.
    Gupta, Arjun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 14 - 14
  • [40] Out-of-pocket costs and affordability of upper limb prostheses
    Resnik, Linda J.
    Borgia, Matthew
    Clark, Melissa A.
    Ni, Pengsheng
    PROSTHETICS AND ORTHOTICS INTERNATIONAL, 2024, 48 (01) : 108 - 114